Muses Labs’ MEND™ Protocol is a new approach to Alzheimer’s disease, bringing together 30 years of scientific research, a team of highly respected Alzheimer’s researchers, doctors, and advanced technology.
Current drug-treatments for Alzheimer’s disease only temporarily help symptoms, and do not halt the decline of cognitive function. Muses Labs’ Protocol is able to transform patient outcomes because it is a combination therapy approach. We are able to target the 50-plus known causes of cognitive decline that often exist simultaneously, and address the causes unique to each patient.
Muses Labs works to identify your unique causes of cognitive decline and provide you with a personalized treatment plan to start on the road back to better cognitive health. Protocol recommendations may include medications, supplements, and lifestyle changes, all of which are personalized to your needs.
Pilot results show that the MEND Protocol has the potential to improve memory and cognitive function in greater than 50% of individuals that followed their personalized Protocol for at least 6 months.
Individuals on the Protocol typically notice changes in memory and cognitive function within 3 months. Not everyone will see changes and your results may vary. The Protocol is designed for individuals with a family history of dementia and for patients with mild cognitive impairment and mild Alzheimer’s disease. The Protocol is best for individuals that are in general good health.
To learn more about Muses Labs and the MEND™ Protocol, please visit our website at www.Museslabs.com.